ORX:STO
Orexo AB
SEKÂ 0.98
arrow_downward
-1.70%(-0.017) 1D
Nov 20, 5:29:34 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 1.05
High
SEKÂ 1.05
Low
SEKÂ 0.93
Mkt. cap
345.30M
Avg. vol.
785.30K
Volume
286.21K
P/E ratio
0.07
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 1.05
High
SEKÂ 1.05
Low
SEKÂ 0.93
Mkt. cap
345.30M
Avg. vol.
785.30K
Volume
286.21K
P/E ratio
0.07
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
Beinsure
·
2 hours ago
S&P 500 forecast for 2027: Wall Street expects a rebound after an 11.6% drop fueled by AI fears
Traders Union
·
5 hours ago
VIX fear index hits highest level since April 2025 as S&P 500 plunges
The Loadstar
·
3 hours ago
CNBC: S&P 500 and Dow close in correction; Nasdaq erases 2026 gain as AI rout picks up steam
JournalArta
·
1 hour ago
S&P 500 Falls Into Correction as AI Worries Deepen
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com